Home Insights Ashfield acquires Research Partnership

Ashfield acquires Research Partnership

2 mins read
3 March 2022

Research Partnership, a leading global healthcare market research and insights company has been acquired by Ashfield. The company will become part of Ashfield’s solution-oriented advisory and consulting division, Ashfield Advisory.

Working with clients in the pharmaceutical, biotech, consumer healthcare and MedTech industries, Research Partnership provides research intelligence on a global basis and throughout the entire lifecycle of products.

The acquisition significantly strengthens and complements the existing Ashfield Advisory offering and Research Partnership will form a new specialist pillar within the business.

Colin Stanley, Global President of Ashfield Advisory said: “I’m so pleased to confirm that Research Partnership is joining our business. The addition of the Research Partnership team will bring a new market research and insights capabilities to our services and allows us to further diversify our geographic reach adding capacity in Asia and an increased footprint in Europe. I look forward to seeing the value our clients will gain from this partnership and an increased suite of connected services.”

Founded in 1997, Research Partnership is headquartered in London with offices in New York, Philadelphia, San Francisco, Lyon, and Singapore. It employs 220+ healthcare experts with in-depth knowledge across the globe, completing projects in over 80 different therapeutic areas.

Commenting on the acquisition, Mary Assimakopoulos, Founding Director of Research Partnership said: “This acquisition brings great opportunities to both our current and future clients, as we’ll be able to offer the same exceptional service, with the added value of being connected to the wider Ashfield offering, as and when our clients need additional support.

“I am extremely proud of the team at Research Partnership and of what we have achieved together. I am very grateful for all their hard work, and I am looking forward to seeing what we can accomplish as part of Ashfield Advisory.”